Skip to main content
. 2018 Aug 10;6(8):E1020–E1030. doi: 10.1055/a-0614-2202

Table 2. Univariate and multivariate analyses of predictive factors of ENBD effectiveness.

  ENBD effectiveness Univariate Multivariate
Variables Presence (n = 114) Absence (n = 31) P OR (95 % CI) P
Age, y (range)     0.324    
  68 (34 – 89) 70 (50 – 90)      
Gender     0.535    

  • Male

 78 23      

  • Female

 36  8      
Bismuth-Corlette criteria, n     0.245    

  • I, II

 21  3      

  • III, IV

 93 28      
Pre-ENBD cholangitis     0.301    

  • With

 20  8      

  • Without

 94 23      
Pre-ENBD total serum bilirubin value (range) (mg/dL)  < 0.001 1.11 (1.05 – 1.18)  < 0.001
  3.9 (1.9 – 32.1) 13.75 (3.1 – 33.1)      
Previous EBS     0.993    

  • With

 33  9      

  • Without

 81 22      
Previous EST     0.09   0.107

  • With

 36  5      

  • Without

 78 26      
Post ENBD cholangitis     0.233    

  • With

 25 10      

  • Without

 89 21      
ENBD catheter     0.325    

  • c-ENBD (7Fr)

 77 18      

  • m-ENBD (6Fr)

 37 13      
Duration of ENBD, d (range)     0.033 0.120
  37 (3 – 144) 24 (3 – 96)      
PVE      < 0.001 0.001

  • With

 77 10   1  

  • Without

 37 21   4.60 (1.82 – 11.6)  

ENBD, endoscopic nasobiliary drainage; EBS,endoscopic biliary stenting; EST, endoscopic sphincterotomy; c-ENBD, conventional ENBD catheter; m-ENBD, modified ENBD catheter: PVE, portal vein embolization